(Q33816182)

English

Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24927744%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Kathleen Bennett

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24927744%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24927744%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

11

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24927744%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

12

object named as

Corinne Zara

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24927744%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Alexander E Finlayson

6

object named as

Alexander E Finlayson

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24927744%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

author name string

Max Petzold

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24927744%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Marion Bennie

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24927744%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Anna Bucsics

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24927744%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Andrew Martin

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24927744%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Marie Persson

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24927744%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Jutta Piessnegger

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24927744%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Corrado Barbui

13

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24927744%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

language of work or name

0 references

publication date

13 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24927744%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24927744%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

98

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24927744%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Trends in use of antipsychotics in elderly patients with dementia: Impact of national safety warnings

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Personalizing health care: feasibility and future implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Differential impact of two risk communications on antipsychotic prescribing to people with dementia in Scotland: segmented regression time series analysis 2001-2011

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Generic medicines: solutions for a sustainable drug market?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Are prescribing initiatives readily transferable across classes: the case of generic losartan in Scotland?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Assessing quality in cross-country comparisons of health systems and policies: towards a set of generic quality criteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Pharmacist-patient communication in Swedish community pharmacies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Influence of multiple initiatives in Sweden to enhance ARB prescribing efficiency following generic losartan; findings and implications for other countries

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Antipsychotics and torsadogenic risk: signals emerging from the US FDA Adverse Event Reporting System database.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Potential to enhance the prescribing of generic drugs in patients with mental health problems in austria; implications for the future

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Proton pump inhibitors: potential cost reductions by applying prescribing guidelines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Pharmaceutical policies in European countries in response to the global financial crisis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

The costs of schizophrenia and predictors of hospitalisation from the statutory health insurance perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

The impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on prescribing practices: an analysis of data from a large midwestern state

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Clozapine safety, 35 years later

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

The impact of reference-pricing systems in Europe: a literature review and case studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Second generation antipsychotics in the treatment of bipolar depression: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Policies to enhance prescribing efficiency in europe: findings and future implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Influence of demand-side measures to enhance renin-angiotensin prescribing efficiency in Europe: implications for the future

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Comparative safety of antipsychotics in the WHO pharmacovigilance database: the haloperidol case.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Patterns and predictors of antipsychotic medication use among the U.S. population: findings from the Medical Expenditure Panel Survey.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Influence of patient co-payments on atypical antipsychotic choice in Poland: implications once generic atypicals are available

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Increasing off-label use of antipsychotic medications in the United States, 1995-2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Clozapine versus other atypical antipsychotics for schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Treatment options for bipolar depression: a systematic review of randomized, controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Generic and therapeutic substitutions in the UK: are they a good thing?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Olanzapine versus other atypical antipsychotics for schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Policies to enhance the efficiency of prescribing in the Spanish Catalan region: impact and future direction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Initial effects of a reimbursement restriction to improve the cost-effectiveness of antihypertensive treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Drug-induced torsades de pointes: data mining of the public version of the FDA Adverse Event Reporting System (AERS).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Atypical antipsychotic drugs and the risk of sudden cardiac death

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

The spurious advance of antipsychotic drug therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Principles of antipsychotic prescribing for policy makers, circa 2008. Translating knowledge to promote individualized treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Adverse effects of atypical antipsychotics : differential risk and clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Switching statins in Norway after new reimbursement policy: a nationwide prescription study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Modern antipsychotic drugs: a critical overview

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Atypical antipsychotics: from potassium channels to torsade de pointes and sudden death

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Different versions of the anatomical therapeutic chemical classification system and the defined daily dose--are drug utilisation data comparable?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

4 July 2018

Cost of treatment of schizophrenia in six European countries.

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-98

21 January 2018

Collaborative prescribing: a qualitative exploration of a role for pharmacists in mental health

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-98

21 January 2018

Factors influencing the choice of new generation antipsychotic medication in the treatment of patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-98

21 January 2018

A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia.

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-98

21 January 2018

Impact of safety warnings on antipsychotic prescriptions in dementia: nothing has changed but the years and the substances

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-98

21 January 2018

Evaluation of the clinical outcomes of switching patients from atorvastatin to simvastatin and losartan to candesartan in a primary care setting: 2 years on.

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-98

21 January 2018

Update of recent reforms in Germany to enhance the quality and efficiency of prescribing of proton pump inhibitors and lipid-lowering drugs

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-98

21 January 2018

Are specific initiatives required to enhance prescribing of generic atypical antipsychotics in Scotland?: International implications.

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-98

21 January 2018

Generic atypical antipsychotic drugs in Belgium: their influence and implications

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-98

21 January 2018

Changes in the utilization of venlafaxine after the introduction of generics in Sweden

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-98

21 January 2018

Evidence-based pharmacotherapy of schizophrenia.

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-98

21 January 2018

Measures to improve angiotensin receptor blocker prescribing efficiency in the UK: findings and implications.

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-98

21 January 2018

Coping with changes in the Defined Daily Dose in a longitudinal drug consumption database

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-98

21 January 2018

Use of Generics-A Critical Cost Containment Measure for All Healthcare Professionals in Europe?

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-98

21 January 2018

Generic olanzapine: health authority opportunity or nightmare?

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-98

21 January 2018

Off-label use of antipsychotic medications in Medicaid.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

30 October 2018

Assessing cost-effectiveness of drug interventions for schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073810

30 October 2018

Pharmacists’ experiences and attitudes regarding generic drugs and generic substitution: two sides of the coin

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-98

21 January 2018

Segmented regression analysis of interrupted time series studies in medication use research

1 reference

https://pubmed.ncbi.nlm.nih.gov/24927744

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

What are the obstacles to generic substitution? An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden

1 reference

https://pubmed.ncbi.nlm.nih.gov/24927744

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

European countries with small populations can obtain low prices for drugs: Lithuania as a case history

1 reference

https://pubmed.ncbi.nlm.nih.gov/24927744

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The NIMH-CATIE Schizophrenia Study: what did we learn?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24927744

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1741-7015-12-98

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24927744%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24927744%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24927744%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33816182&oldid=2195824769"